Skip to main content
Table of Contents
Print

Can some cancer treatments or other medicines lead to heart failure? 

Author: Harry Whitmore, Medical Student | Reviewed by: Dr. Rebecca Fernandez, MBBS

While the primary goal of medical treatment is to cure or manage a specific illness, some therapies can have unintended effects on other organs. One of the most significant concerns is ‘cardiotoxicity’, where a drug or treatment damages the heart muscle or affects its rhythm. This is most commonly discussed in the context of cancer treatment, but it also applies to several everyday medications used for other conditions. Understanding these risks allows you and your medical team to monitor your heart health closely and take preventive action if needed. 

What We’ll Discuss in This Article 

  • The definition of cardiotoxicity in cancer treatment 
  • Which chemotherapy drugs are most likely to affect the heart 
  • The impact of radiotherapy on heart tissue 
  • Other common non-cancer medications that can cause heart strain 
  • Why NSAIDs like ibuprofen are risky for heart failure patients 
  • How doctors monitor your heart during medical treatment 
  • When to seek urgent medical advice 

Can cancer treatments cause heart failure? 

Yes, certain cancer treatments can lead to heart failure, a field of medicine known as cardio-oncology. Some chemotherapy drugs and types of radiotherapy are known to be cardiotoxic, meaning they can weaken the heart muscle, cause inflammation, or disrupt the heart’s electrical system. 

Chemotherapy and Targeted Therapies 

  • Anthracyclines (e.g., Doxorubicin): These are powerful drugs used for various cancers, including breast cancer and leukaemia. They can cause direct, permanent damage to the heart muscle cells, leading to a weak pump (reduced ejection fraction). 
  • Trastuzumab (Herceptin): Used for certain types of breast cancer, this targeted therapy can cause heart failure, though the damage is often reversible once the drug is stopped. 
  • Immune Checkpoint Inhibitors: These newer immunotherapy drugs can occasionally cause myocarditis (inflammation of the heart muscle), which can lead to acute heart failure. 

Radiotherapy 

Radiotherapy to the chest area (for example, for lung cancer or Hodgkin lymphoma) can damage the heart’s valves, arteries, or the protective sac around the heart (pericardium). This damage may not appear until many years after the treatment has finished. 

Clinical Context 

According to the British Heart Foundation, patients undergoing these treatments are now monitored much more closely with regular echocardiograms (heart scans) to catch any decline in function early. 

Which other medicines can lead to heart failure? 

It is not only cancer treatments that can affect the heart. Several common medications used for chronic conditions can either cause new heart failure or worsen a stable condition. 

Common Medications of Concern 

  • NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Medicines like ibuprofen, naproxen, and high-dose aspirin can cause the body to retain salt and water. For someone with an already vulnerable heart, this fluid retention can trigger acute heart failure. 
  • Some Diabetes Medications: Certain older drugs in the thiazolidinedione class (like pioglitazone) are known to increase the risk of fluid retention and heart failure. 
  • Certain Antifungals: Drugs like itraconazole have been linked to a temporary weakening of the heart muscle. 
  • Calcium Channel Blockers: While used to treat high blood pressure, some types (like diltiazem or verapamil) can slow the heart rate too much or weaken the contraction in patients who already have heart failure. 

How do these medicines damage the heart? 

Medicines can damage the heart through several different biological pathways, depending on the chemical structure of the drug. 

Mechanisms of Damage 

  • Direct Toxicity: The drug kills heart muscle cells (myocytes), which are then replaced by scar tissue that cannot pump. 
  • Fluid Retention: The drug affects the kidneys, forcing the body to hold onto salt and water. This increases blood volume and puts massive mechanical strain on the heart. 
  • Electrical Disruption: Some drugs interfere with the electrolytes (like potassium) that control the heart’s rhythm, leading to arrhythmias that make the pump inefficient. 

Triggers and Risk Factors 

Not everyone who takes these medications will develop heart failure. Certain factors make an individual more susceptible to treatment-related heart damage. 

  • Pre-existing Conditions: Having high blood pressure, diabetes, or previous heart damage significantly increases the risk. 
  • Age: Older adults and very young children are more vulnerable to cardiotoxic effects. 
  • Dosage: For many chemotherapy drugs, the risk is cumulative, meaning the higher the total dose received over time, the higher the risk. 
  • Combination Therapy: Receiving both chemotherapy and radiotherapy to the chest increases the combined risk. 

Differentiation: Medication Side Effect vs Worsening Disease 

It can be difficult to tell if symptoms are a direct side effect of a drug or if an underlying heart condition is getting worse on its own. 

Medication Side Effect 

  • Timing: Symptoms often start shortly after beginning a new medication or increasing a dose. 
  • Nature: May include sudden ankle swelling (common with some blood pressure drugs) or a dry cough (common with ACE inhibitors). 
  • Resolution: Symptoms often improve quickly if the offending drug is stopped under medical supervision. 

Heart Failure Progression 

  • Timing: Symptoms develop gradually over months. 
  • Nature: Persistent fatigue, worsening breathlessness on exertion, and orthopnoea (breathlessness when lying flat). 
  • Resolution: Requires the addition of heart-specific medications to stabilise. 

Conclusion 

Many essential medical treatments, including certain chemotherapies and common anti-inflammatory drugs, can lead to heart failure by damaging the heart muscle or causing fluid retention. Cardiotoxicity is a serious concern, but modern medical practice involves rigorous monitoring to detect early changes in heart function. By understanding which medications carry these risks, you can stay vigilant for early signs like swelling or breathlessness and ensure your heart health is protected throughout your treatment journey. 

Emergency Guidance 

If you experience sudden, severe breathlessness, chest pain, or fainting while undergoing cancer treatment or after starting a new medication, call 999 immediately. These can be signs of acute heart failure or myocarditis requiring urgent hospital care. 

FAQ Section 

1. Should I stop taking my medication if I’m worried about my heart? 

No. Never stop prescribed medication, especially cancer treatment or blood pressure drugs, without consulting your specialist. Stopping suddenly can be more dangerous than the side effects. 

2. Can I take ibuprofen if I have heart failure? 

According to the NHS, people with heart failure should generally avoid NSAIDs like ibuprofen as they cause fluid retention. Paracetamol is usually a safer alternative for pain relief. 

3. Is heart damage from chemotherapy permanent? 

It depends on the drug. Damage from anthracyclines is often permanent, but damage from other drugs like trastuzumab is frequently reversible if caught early and treated. 

4. How do doctors monitor my heart during chemotherapy? 

The most common method is a baseline echocardiogram (heart ultrasound) before treatment starts, followed by regular scans every few months to monitor your ‘ejection fraction’ (pumping power). 

5. Can radiotherapy from years ago affect my heart now? 

Yes. Radiation-induced heart disease can take 10, 20, or even 30 years to manifest as valve problems or narrowed arteries. Always mention past radiotherapy to your doctor. 

6. Are newer cancer treatments safer for the heart? 

Some are, but even newer immunotherapies carry their own risks, such as inflammation of the heart muscle (myocarditis). Each drug has a different safety profile. 

7. Can heart medication protect me during chemotherapy? 

Sometimes. In high-risk patients, doctors may prescribe heart-protective drugs like beta-blockers or ACE inhibitors alongside chemotherapy to reduce the chance of damage. 

Authority Snapshot 

This article was written by Dr. Rebecca Fernandez, a UK-trained physician with extensive experience in cardiology, internal medicine, and emergency care. Dr. Fernandez has managed critically ill patients and provided comprehensive care for acute and chronic conditions within the NHS framework. This guide uses established clinical data and NHS protocols to explain the link between certain medical treatments and heart function, ensuring accurate and medically safe information. 

Harry Whitmore, Medical Student
Author
Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories